Valinor offers an AI‑driven platform that unifies diverse omics, imaging, and clinical datasets—such as single‑cell RNA‑seq, ATAC‑seq, whole‑genome sequencing, proteomics, spatial omics, radiology, histopathology, ctDNA, and treatment histories—into a single analytical workspace. The platform creates automated patient simulations and predictive models to forecast disease progression, therapeutic response, and biomarker relevance, helping pharmaceutical and biotech teams prioritize drug candidates and reduce late‑stage failures. Results are delivered via interactive dashboards, APIs, and SDKs that integrate with existing R&D pipelines.
Funding
Funding not disclosed
Founders
Product
Problem
Drug discovery and development involve integrating vast, heterogeneous biological and clinical datasets, which is time‑consuming and prone to errors. The complexity of these data hampers the ability to predict patient responses, leading to high attrition rates and costly late‑stage failures.
Solution
Valinor provides an AI‑driven platform that consolidates multi‑modal datasets—including single‑cell RNA‑seq, ATAC‑seq, whole‑genome sequencing, proteomics, spatial omics, radiology imaging, histopathology, ctDNA, and clinical treatment histories—into a unified analytical environment. The platform trains automated patient simulations on the largest longitudinal clinical collections available, enabling researchers to model disease progression and therapeutic response across diverse patient cohorts. Machine‑learning models generate predictive biomarkers and efficacy forecasts, allowing teams to prioritize the most promising candidates before entering expensive clinical trials. Results are delivered through interactive dashboards and APIs that integrate with existing drug‑development workflows, reducing data‑handling overhead and accelerating decision‑making.
Target Audience
Primary customers are pharmaceutical companies, biotechnology firms, and contract research organizations that need to integrate complex molecular and clinical data to accelerate preclinical and early‑clinical decision making.
Features
- Integrated ingestion pipeline for over a dozen omics and imaging data types, standardizing formats and metadata
- Automated, ML‑based patient cohort simulations that model longitudinal disease trajectories and treatment effects
- Predictive analytics for efficacy, safety, and biomarker discovery using deep‑learning models trained on extensive clinical histories
- Cloud‑native analytics workspace with customizable visualizations, cohort comparison tools, and exportable reports
- API and SDK support for seamless incorporation into existing R&D pipelines and data lakes
- Secure, HIPAA‑compliant data storage with role‑based access controls and audit logging